Quarterly report · Q1
3341.TEDINET S100RN0R
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥81.8bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥313.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥74.7bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥1.6bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥892m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.6bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥7.7bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥913m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.6bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥925m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥659m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.5bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥391m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥659m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥391m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥199.2bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥185.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥195.3bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥142.4bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥128.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥56.8bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥56.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥52.9bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥31.2bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥23.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥22.06 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥148.92 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.05 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 28.5% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.1% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥3.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥3.6bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥1.9bn |
| jpcrp040300-q1r_E05422-000Dispensing Pharmacy Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥72.3bn |
| jpcrp040300-q1r_E05422-000Dispensing Pharmacy Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥72.3bn |
| jpcrp040300-q1r_E05422-000Dispensing Pharmacy Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥2.9bn |
| jpcrp040300-q1r_E05422-000Medical Professional Staffing And Placement Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥2.6bn |
| jpcrp040300-q1r_E05422-000Medical Professional Staffing And Placement Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥2.6bn |
| jpcrp040300-q1r_E05422-000Medical Professional Staffing And Placement Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥5m |
| jpcrp040300-q1r_E05422-000Medical Professional Staffing And Placement Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥484m |
| jpcrp040300-q1r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥10.5bn |
| jpcrp040300-q1r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥7.0bn |
| jpcrp040300-q1r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥3.6bn |
| jpcrp040300-q1r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥126m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-06-30 | ¥85.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-06-30 | ¥81.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥3.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-06-30 | ¥3.5bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥3.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥3.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥1.8bn |
| jpcrp040300-q1r_E05422-000Dispensing Pharmacy Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥66.4bn |
| jpcrp040300-q1r_E05422-000Dispensing Pharmacy Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥66.4bn |
| jpcrp040300-q1r_E05422-000Dispensing Pharmacy Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q1r_E05422-000Medical Professional Staffing And Placement Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q1r_E05422-000Medical Professional Staffing And Placement Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q1r_E05422-000Medical Professional Staffing And Placement Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥3m |
| jpcrp040300-q1r_E05422-000Medical Professional Staffing And Placement Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥355m |
| jpcrp040300-q1r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥10.0bn |
| jpcrp040300-q1r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥6.3bn |
| jpcrp040300-q1r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥3.8bn |
| jpcrp040300-q1r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥270m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥78.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥74.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥2.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 351
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 2061400 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 2061400 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0643 | |
| Cash and deposits | Prior1YearInstant | 23770000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 31226000000 | JPY |
| Notes receivable trade | Prior1YearInstant | 70000000 | JPY |
| Notes receivable trade | CurrentQuarterInstant | 107000000 | JPY |
| Trade receivables and contract asset ca | Prior1YearInstant | 21246000000 | JPY |
| Trade receivables and contract asset ca | CurrentQuarterInstant | 20523000000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 437000000 | JPY |
| Electronically recorded monetary claims operating ca | CurrentQuarterInstant | 235000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 28416000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 33901000000 | JPY |
| Work in process | Prior1YearInstant | 1742000000 | JPY |
| Work in process | CurrentQuarterInstant | 1522000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 6021000000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 5785000000 | JPY |
| Other ca | Prior1YearInstant | 4022000000 | JPY |
| Other ca | CurrentQuarterInstant | 4624000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -6000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -7000000 | JPY |
| Current assets | Prior1YearInstant | 85720000000 | JPY |
| Current assets | CurrentQuarterInstant | 97919000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 28361000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 28094000000 | JPY |
| Land | Prior1YearInstant | 13377000000 | JPY |
| Land | CurrentQuarterInstant | 13377000000 | JPY |
| Construction in progress | Prior1YearInstant | 1828000000 | JPY |
| Construction in progress | CurrentQuarterInstant | 1779000000 | JPY |
| Other net ppe | Prior1YearInstant | 17867000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 17630000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 61435000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 60881000000 | JPY |
| Goodwill | Prior1YearInstant | 14195000000 | JPY |
| Goodwill | CurrentQuarterInstant | 14004000000 | JPY |
| Other ia | Prior1YearInstant | 5377000000 | JPY |
| Other ia | CurrentQuarterInstant | 5809000000 | JPY |
| Intangible assets | Prior1YearInstant | 19573000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 19814000000 | JPY |
| Investment securities | Prior1YearInstant | 16000000 | JPY |
| Investment securities | CurrentQuarterInstant | 16000000 | JPY |
| Lease and guarantee deposits | Prior1YearInstant | 9160000000 | JPY |
| Lease and guarantee deposits | CurrentQuarterInstant | 10589000000 | JPY |
| Other ioa | Prior1YearInstant | 9391000000 | JPY |
| Other ioa | CurrentQuarterInstant | 9978000000 | JPY |
| Investments and other assets | Prior1YearInstant | 18568000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 20585000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 99576000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 101281000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |